GlassScriptPhysician profile
James Liao
NPI 1881057339
$26,637.04
in general payments reported to CMS, 2019-2025
10 companies · $23.64 in 2025
The $23.64 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.46 · 2020: $25K · 2021: $1,189 · 2022: $84.71 · 2023: $64.17 · 2024: $95.10 · 2025: $23.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $182.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $25,000.00 | 2020 | |
| Medtronic, INC. | $1,369.26 | 2021-2024 | Percept PC Brainsense |
| Acadia Pharmaceuticals INC | $64.17 | 2023 | Nuplazid |
| Csl Behring | $54.03 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $41.88 | 2020 | |
| Alexion Pharmaceuticals, INC. | $26.17 | 2019 | |
| Genentech USA, INC. | $23.95 | 2019-2020 | |
| Abbvie INC. | $23.64 | 2025 | |
| Assertio Therapeutics, INC. | $17.08 | 2020 | |
| Genzyme Corporation | $16.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Liao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.